LMR Partners LLP Acquires 13,037 Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA)

LMR Partners LLP boosted its stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 130.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 23,037 shares of the company's stock after acquiring an additional 13,037 shares during the period. LMR Partners LLP owned 0.08% of Establishment Labs worth $1,061,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in ESTA. Quarry LP purchased a new stake in Establishment Labs in the 4th quarter valued at approximately $27,000. R Squared Ltd purchased a new stake in shares of Establishment Labs during the 4th quarter worth approximately $36,000. KLP Kapitalforvaltning AS purchased a new stake in shares of Establishment Labs during the 4th quarter worth approximately $161,000. Hood River Capital Management LLC boosted its stake in shares of Establishment Labs by 236.4% during the 4th quarter. Hood River Capital Management LLC now owns 5,920 shares of the company's stock worth $273,000 after acquiring an additional 4,160 shares in the last quarter. Finally, Handelsbanken Fonder AB raised its position in shares of Establishment Labs by 32.3% during the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock worth $378,000 after purchasing an additional 2,000 shares during the last quarter. Institutional investors and hedge funds own 72.91% of the company's stock.

Establishment Labs Price Performance

Shares of NASDAQ ESTA traded down $0.46 during mid-day trading on Friday, reaching $36.16. 305,093 shares of the company traded hands, compared to its average volume of 470,272. The firm has a market cap of $1.05 billion, a PE ratio of -14.02 and a beta of 0.73. The stock has a fifty day simple moving average of $34.41 and a 200-day simple moving average of $38.26. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. Establishment Labs Holdings Inc. has a fifty-two week low of $26.56 and a fifty-two week high of $59.00.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported ($0.70) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.83) by $0.13. The firm had revenue of $41.38 million during the quarter, compared to analysts' expectations of $41.15 million. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. Establishment Labs's revenue for the quarter was up 11.3% on a year-over-year basis. During the same period in the prior year, the company posted ($0.58) earnings per share. Equities research analysts anticipate that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently issued reports on ESTA. Needham & Company LLC raised Establishment Labs from a "hold" rating to a "buy" rating and set a $48.00 target price on the stock in a research note on Wednesday. Stephens reissued an "overweight" rating and set a $52.00 price target on shares of Establishment Labs in a research note on Thursday, March 6th. Finally, BTIG Research assumed coverage on Establishment Labs in a research note on Friday. They set a "buy" rating and a $62.00 price target on the stock. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $55.33.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.